NCT07814014Recruiting
Real-world Insight Into Systemic Therapies for HCC: Single-center Study
Real-world Insight Into Systemic Therapies for Hepatocellular Carcinoma: a Comprehensive Single-center Study
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving systemic therapies
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 27 Aug 2026
- Start date
- 1 Aug 2026
- Primary completion date
- 15 Dec 2027
- Lead sponsor
- Mansoura University
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07814014
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Aug 2026 to the primary completion date, 15 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients eligible for treatment other than systemic therapy according to Barcelona Clinic liver cancer.
Other
- patient with other tumor than HCC
- Child-Turcotte-Pugh score B (8,9) and C.
Who the study is looking for
- patient with HCC
- Child-Pugh class A, B7
- Performance state 0-1 (Eastern Cooperative Oncology Group (ECOG scale).
- Barcelona Clinic Liver Cancer (BCLC) stage C or BCLC stage B with diffuse, infiltrative or extensive bilobar involvement or BCLC stage B with tumor progression after TACE.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mansoura University Hospitals Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.